HEPARIN SODIUM

Generic: HEPARIN SODIUM

CivicaManufacturer
INTRAVENOUS, SUBCUTANEOUSRoute
HEPARIN SODIUMActive Substance
1972-03-22Original Approval

HEPARIN SODIUM is FDA application NDA017037, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2023-03-01
Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.B

Subpotent Drug: low Anti-Factor IIa potency.

Class II2019-06-13
Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextrose Injection, 250 mL EXCEL Container bag,

Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potenc

Class I2024-08-01
Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Singl

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Class II2015-06-03
Heparin Sodium and 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx Only,

Subpotent Drug; out of specification results for heparin raw material

Class II2022-12-29
Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case

Lack of assurance of sterility: Bags have the potential to leak.

Class II2026-10-01
Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink U

Lack of Assurance of Sterility

Class II2014-06-06
Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Si

Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of

Class I2014-09-11
HEPARIN SODIUM, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL flexib

Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the

Class II2023-02-28
Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutan

Labeling: Not elsewhere classified

Class II2023-05-09
Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B.

Subpotent: Low anti-factor IIa Potency.

Top Reported Reactions

1
HEPARIN-INDUCED THROMBOCYTOPENIA
1,345 reports
2
DRUG INEFFECTIVE
1,329 reports
3
OFF LABEL USE
801 reports
4
NAUSEA
769 reports
5
DRUG HYPERSENSITIVITY
654 reports
6
VOMITING
632 reports
7
HYPOTENSION
586 reports
8
DYSPNOEA
568 reports
9
PULMONARY EMBOLISM
544 reports
10
SEPSIS
520 reports